Biomarkers and Therapeutics for Parkinson's Disease

Dear Colleagues,

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. PD is caused by a loss of nerve cells in the part of the brain called the substantia nigra. This leads to a reduction in a chemical called dopamine in the brain. Dopamine plays a vital role in regulating the movement of the body. A reduction in dopamine is responsible for many of the symptoms of PD.

There is no cure for PD and treatment aims to improve the symptoms. Since there is no accurate test method for PD, the diagnosis of PD is mainly based on symptoms, with tests such as neuroimaging used to rule out other diseases. Therefore, research on biomarkers and various therapeutics for PD is very important in order to establish a PD diagnosis and treatment strategy.

This Special Issue aims to collect original research articles describing in vivo and/or in vitro assays that enhance our understanding of diagnosis and treatment in the field of PD. Of particular interest are studies that illustrate the effect and mechanism of medication, acupuncture, and medicinal herbs on PD. Studies that present strategies including biomarkers for the diagnosis of PD are also welcome.

Dr. Seungtae Kim
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.